ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
291 hedge funds and large institutions have $4.54B invested in Intra-Cellular Therapies Inc. in 2023 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 122 increasing their positions, 89 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
15% less capital invested
Capital invested by funds: $5.34B → $4.54B (-$799M)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
Holders
291
Holding in Top 10
8
Calls
$13.2M
Puts
$13M
Top Buyers
1 | +$54.8M | |
2 | +$52.2M | |
3 | +$41.7M | |
4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$31.3M |
5 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
+$21.1M |
Top Sellers
1 | -$53.1M | |
2 | -$33.4M | |
3 | -$15.6M | |
4 |
Man Group
London,
United Kingdom
|
-$14.5M |
5 |
Holocene Advisors
New York
|
-$13.7M |